Equity Analysis /
United States of America

US : CymaBay Therapeutics, Inc. - CBAY | 3Q21 Update: Phase 3 Tracking Well; Long-Term Data at AASLD

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    11 November 2021
    Published by